Alexander M Klibanov

This inventor holds 39 USPTO granted patents and 17 published patent applications, plus 5 CIPO patents and 6 EPO patents, primarily in Liquid Protein Formulations. Top assignees: Eagle Biologics, Inc., Massachusetts Institute of Technology, Collegium Pharmaceutical, Inc.. Active years: 1983-2024.

USPTO Granted Patents = 39 (Patent Applications = 17)

% Patents Active = 79.5

CIPO Patents = 5 (Patent Applications = 3)

EPO Patents = 6 (Patent Applications = 14)

Average Co-Inventor Count = 3.3

ph-index = 16

Forward Citations = 1,303(Granted Patents)

Location History:

Newton, MA (US) (1989 - 2015)
Boston, MA (US) (1983 - 2024)

Company Filing History:

11 out of 11

Eagle Biologics, Inc.

patents

11 out of 8,576

Massachusetts Institute of Technology

patents

9 out of 28

Collegium Pharmaceutical, Inc.

patents

4. 4 out of 14

Cambridge Scientific, Inc.

University of Pennsylvania

patents

7. 1 out of 11

Capitol Specialty Plastics, Inc.

where one patent can have more than one assignee

Years Active: 1983-2024

Loading Chart...

Areas of Expertise:

Liquid Protein Formulations

Abuse-Deterrent Drugs

Antibacterial Coatings

Nucleic Acid Formulations

Viscosity-Lowering Agents

Pharmaceutical Compositions

Enzymatic Production

Biodegradable Devices

Resorbable Fusion Devices

Pulmonary Delivery

Macromolecule Solutions

Temperature Change Indicators

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11986526 - Liquid protein formulations containing 4-ethyl-4-methylmorpholinium methylcarbonate (EMMC) (2024-05-21),

2. 11819550 - Liquid protein formulations containing cyclic adenosine monophosphate (cAMP) or adenosine triphosphate (ATP) (2023-11-21),

3. 11471479 - Polysaccharide and nucleic acid formulations containing viscosity-lowering agents (2022-10-18),

4. 10849977 - Liquid Protein Formulations Containing Thiamine (2020-12-01),

5. 10821184 - Liquid protein formulations containing thiamine pyrophosphate (TPP) (2020-11-03),

6. 10821183 - Liquid protein formulations containing 4-(3-butyl-1-imidazolio)-1-butane sulfonate (BIM) (2020-11-03),

7. 10646571 - Liquid protein formulations containing cimetidine (2020-05-12),

8. 10525053 - Abuse-deterrent pharmaceutical compositions of opioids and other drugs (2020-01-07),

9. 10525052 - Abuse-deterrent drug formulations (2020-01-07),

10. 10500317 - Antibacterial coatings that inhibit biofilm formation on implants (2019-12-10),

11. 10179172 - Liquid pharmaceutical formulations for injection comprising yellow 5 or orange G and uses thereof (2019-01-15),

12. 9925263 - Liquid pharmaceutical formulations for injection comprising procaine and uses thereof (2018-03-27),

13. 9913905 - Liquid pharmaceutical formulations for injection comprising thiamine pyrophosphate 1-(3-aminopropyl)-2-methyl-1H-imidazole and uses thereof (2018-03-13),

14. 9833513 - Liquid protein formulations for injection comprising 1-butyl-3-methylimidazolium methanesulfonate and uses thereof (2017-12-05),

15. 9763883 - Abuse-deterrent drug formulations (2017-09-19),

Title: The Innovative Journey of Alexander M Klibanov

Introduction:

Alexander M Klibanov is a renowned inventor based in Boston, MA. He has made significant contributions to the field of innovations and patents, particularly in the realm of biotechnology and medical devices.

Latest Patents:

Alexander M Klibanov holds several patents in the areas of drug delivery systems, medical imaging technologies, and biomaterials. His recent patents showcase his commitment to advancing healthcare through innovative solutions.

Career Highlights:

With a background in bioengineering and pharmaceutical sciences, Alexander M Klibanov has had a distinguished career marked by groundbreaking inventions. His work has not only revolutionized the medical industry but has also improved the quality of life for many individuals.

Collaborations:

Throughout his career, Alexander M Klibanov has collaborated with leading researchers, scientists, and medical professionals to bring his inventions to life. His collaborative efforts have led to the development of cutting-edge technologies that have had a lasting impact on the healthcare sector.

Conclusion:

In conclusion, Alexander M Klibanov's passion for innovation and his dedication to improving healthcare have solidified his reputation as a pioneering inventor. His contributions continue to inspire the next generation of inventors and shape the future of the industry.